Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 215-572-9 | CAS number: 1332-65-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 1 mg/m³
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 1 mg/m³
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 137 mg/kg bw/day
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - workers
In order to set acceptable DNEL values it is imperative that the determination takes into account the class of compound under review. It is impossible to investigate the exposure to copper and copper compounds without considering that copper is an essential metal present in human body tissues and fluids at concentrations of parts per million or parts per billion. It is also under tight homeostatic mechanisms that can control excess copper exposure by changing the rate of systemic uptake or excretion via the bile in humans. Therefore, in assessing the human health effects of copper the essentiality and homeostatic mechanisms have to be taken into account. In addition, for copper there are both animal studies and human volunteer studies available to determine an appropriate DNEL. For the purposes of this risk assessment, the values used in the human health risk assessment will be determined using both the animal and human data. It will be seen that the outcome of this evaluation is very similar.
Long-term systemic DNEL for workers and general population:
This document describes the derivation of a long term DNEL for copper and copper compounds based on homeostatic mechanisms involved in the oral absorption and bioavailability of copper in both rats and humans, available mammalian toxicity data and the understanding that copper is an essential metal.
In deriving a long term DNEL for a substance, there are several factors that have to be taken into account in determining the global assessment factor to be used in the risk characterization. The default values are set as:
Interspecies variation: This is based on the allometric scale as discussed in the Technical Guidance Document and the RIP-8 for human health under REACH and an additional interspecies factor to take into account other differences/similarities between species.
The default values for interspecies variability are as follows:
Allometric scaling based on rat studies 4
Other interspecies differences 2.5
Overall total 10
Intraspecies variation: In the TGD and RIP-8 for REACH the default value for intraspecies variation is 10. This can be reduced when for instance, the risk characterization only considers a sub-population e.g. workers.
Sub-chronic to chronic factor. If no reliable chronic studies are available, then a default value of 2 is used to determine a long term AEL from sub-chronic NOAELs (e.g. 90 day studies).
It is proposed that the assessment factors used in setting the long-term systemic DNEL for copper should be based on the following assessment factors:
|
Default Values |
Proposed Assessment Factor for copper |
Interspecies variation: Allometric scaling – rat Other interspecies variability |
4 2.5 |
4 1.25 |
Intraspecies variation |
10 |
10 |
Subchronic-chronic factor |
2 |
2 |
Proposed assessment factor for long term AEL |
200 |
100 |
It can be seen from the Table, that the only Assessment Factor to change from the default values is Interspecies variability – other observations. It was considered scientifically invalid to change the other factors, especially workers to general population based on the lack of reliable scientific evidence. Therefore this DNEL is acceptable for workers and general population.
The justification for the reduction from 2.5 to 1.25 was based on the similarities observed between rat and human toxicokinetic mechanism for uptake of copper following oral administration. It was not considered relevant to define factors for dermal and inhalation uptake as the pivotal mammalian toxicity studies (90 day rat dietary study) was based solely on the oral route of administration.
The long-term DNEL is therefore calculated using the following studies/criteria:
Pivotal study 90-day oral repeat dose toxicity study in the rat 16.7 mg/kg bw/d
Oral absorption factor 25%
Assessment factor 100
Long-term systemic DNEL 0.041 mg/kg bw/d
Short-term systemic DNEL:
A short-term systemic DNEL can also be calculated from above by taking into account that the 90-day study is an appropriate term of exposure and removing the need for an assessment factor of 2 (sub-chronic-chronic factor). This would result in a short-term systemic DNEL of 0.082 mg/kg bw/d.
Acute systemic DNEL:
The need for assessment factors for acute effects is based on the NOAEL identified in the human volunteer studies of Araya et al (2001 and 2003). The NOAEL for nausea, the earliest and most frequently reported GIT symptom, was 4 mg Cu/L. In deriving a assessment factors for acute oral effects, it is significant that the NOAEL was derived from an internationally-diverse study population, involving a large number of subjects who were fasted prior to copper consumption and thus most susceptible to copper-induced GIT effects. In addition, the second and largest of the two studies involved only female subjects, who have been shown to be the most sensitive gender with respect to copper-induced GIT symptoms (Araya et al 2001; 2004). Consequently, the study population from which the NOAEL was identified may be considered as representing a fairly worst case. With respect to other members of the general population, the available data do not indicate that children are more at risk of acute effects associated with copper (Olivares et al, 1998; Pettersson et al, 2003). Further, the critical effect involved, a GIT effect, is a local effect which is not affected by toxicokinetic factors and consequently requires no assessment factors to address any uncertainty.
Taking into consideration these factors, an assessment factor of 1 is considered appropriate for acute oral toxicity for the general population. An assessment factor of 1 is also considered appropriate for workers. Therefore the acute DNEL for copper and copper compounds is 4 mg Cu/L.
External Inhalation DNEL:
The NOAEL from a repeatd dose inhalation study is >2 mg/m3. Using this value as a point of departure, corresponding conservative HEC values of 1.5 mg/m3 and 3.6 mg/m3 were derived for hot and cold processes, which can be considered as worst-case values that cover the entire range of processes in the copper industry.
These values are also very close to the existing OEL for copper dust of 1 mg/m3 and as this value is currently used by many Member States as a legislative limit, it is proposed that this value is retained for the purposes of the REACH risk assessments and used as an inhalation local DNEL for copper. The corresponding OEL for copper fume is 0.1 mg/m3.
The external inhalation DNEL (short-term and long-term) is therefore:
1 mg/m3 for copper dust.
0.1 mg/m3 for copper fume.
External Dermal DNEL:
For screening purposes in the human health risk assessment, an external dermal DNEL (short-term and long-term) can be calculated using the proposed systemic DNELs (outlined above) and the proposed dermal penetration factors of 0.03% for dry copper and copper compounds and 0.3% for copper and copper compounds in solution/suspension.
The external long-term DNEL for dermal exposure has been set at 136.67 mg Cu/kg bw/d for dry copper and copper compounds.
The external short-term DNEL for dermal exposure has been set at 273.34 mg Cu/kg bw/d for dry copper and copper compounds.
The external long-term DNEL for dermal exposure has been set at 13.67 mg Cu/kg bw/d for copper and copper compounds in a slurry/solution.
The external short-term DNEL for dermal exposure has been set at 27.33 mg Cu/kg bw/d for copper and copper compounds in a slurry/solution.
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.041 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.082 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - General Population
In order to set acceptable DNEL values it is imperative that the determination takes into account the class of compound under review. It is impossible to investigate the exposure to copper and copper compounds without considering that copper is an essential metal present in human body tissues and fluids at concentrations of parts per million or parts per billion. It is also under tight homeostatic mechanisms that can control excess copper exposure by changing the rate of systemic uptake or excretion via the bile in humans. Therefore, in assessing the human health effects of copper the essentiality and homeostatic mechanisms have to be taken into account. In addition, for copper there are both animal studies and human volunteer studies available to determine an appropriate DNEL. For the purposes of this risk assessment, the values used in the human health risk assessment will be determined using both the animal and human data. It will be seen that the outcome of this evaluation is very similar.
Long-term systemic DNEL for workers and general population:
This document describes the derivation of a long term DNEL for copper and copper compounds based on homeostatic mechanisms involved in the oral absorption and bioavailability of copper in both rats and humans, available mammalian toxicity data and the understanding that copper is an essential metal.
In deriving a long term DNEL for a substance, there are several factors that have to be taken into account in determining the global assessment factor to be used in the risk characterization. The default values are set as:
Interspecies variation: This is based on the allometric scale as discussed in the Technical Guidance Document and the RIP-8 for human health under REACH and an additional interspecies factor to take into account other differences/similarities between species.
The default values for interspecies variability are as follows:
Allometric scaling based on rat studies 4
Other interspecies differences 2.5
Overall total 10
Intraspecies variation: In the TGD and RIP-8 for REACH the default value for intraspecies variation is 10. This can be reduced when for instance, the risk characterization only considers a sub-population e.g. workers.
Sub-chronic to chronic factor. If no reliable chronic studies are available, then a default value of 2 is used to determine a long term AEL from sub-chronic NOAELs (e.g. 90 day studies).
It is proposed that the assessment factors used in setting the long-term systemic DNEL for copper should be based on the following assessment factors:
|
Default Values |
Proposed Assessment Factor for copper |
Interspecies variation: Allometric scaling – rat Other interspecies variability |
4 2.5 |
4 1.25 |
Intraspecies variation |
10 |
10 |
Subchronic-chronic factor |
2 |
2 |
Proposed assessment factor for long term AEL |
200 |
100 |
It can be seen from the Table, that the only Assessment Factor to change from the default values is Interspecies variability – other observations. It was considered scientifically invalid to change the other factors, especially workers to general population based on the lack of reliable scientific evidence. Therefore this DNEL is acceptable for workers and general population.
The justification for the reduction from 2.5 to 1.25 was based on the similarities observed between rat and human toxicokinetic mechanism for uptake of copper following oral administration. It was not considered relevant to define factors for dermal and inhalation uptake as the pivotal mammalian toxicity studies (90 day rat dietary study) was based solely on the oral route of administration.
The long-term DNEL is therefore calculated using the following studies/criteria:
Pivotal study 90-day oral repeat dose toxicity study in the rat 16.7 mg/kg bw/d
Oral absorption factor 25%
Assessment factor 100
Long-term systemic DNEL 0.041 mg/kg bw/d
Short-term systemic DNEL:
A short-term systemic DNEL can also be calculated from above by taking into account that the 90-day study is an appropriate term of exposure and removing the need for an assessment factor of 2 (sub-chronic-chronic factor). This would result in a short-term systemic DNEL of 0.082 mg/kg bw/d.
Acute systemic DNEL:
The need for assessment factors for acute effects is based on the NOAEL identified in the human volunteer studies of Araya et al (2001 and 2003). The NOAEL for nausea, the earliest and most frequently reported GIT symptom, was 4 mg Cu/L. In deriving a assessment factors for acute oral effects, it is significant that the NOAEL was derived from an internationally-diverse study population, involving a large number of subjects who were fasted prior to copper consumption and thus most susceptible to copper-induced GIT effects. In addition, the second and largest of the two studies involved only female subjects, who have been shown to be the most sensitive gender with respect to copper-induced GIT symptoms (Araya et al 2001; 2004). Consequently, the study population from which the NOAEL was identified may be considered as representing a fairly worst case. With respect to other members of the general population, the available data do not indicate that children are more at risk of acute effects associated with copper (Olivares et al, 1998; Pettersson et al, 2003). Further, the critical effect involved, a GIT effect, is a local effect which is not affected by toxicokinetic factors and consequently requires no assessment factors to address any uncertainty.
Taking into consideration these factors, an assessment factor of 1 is considered appropriate for acute oral toxicity for the general population. An assessment factor of 1 is also considered appropriate for workers. Therefore the acute DNEL for copper and copper compounds is 4 mg Cu/L.
External Inhalation DNEL:
The NOAEL from a repeatd dose inhalation study is >2 mg/m3. Using this value as a point of departure, corresponding conservative HEC values of 1.5 mg/m3 and 3.6 mg/m3 were derived for hot and cold processes, which can be considered as worst-case values that cover the entire range of processes in the copper industry.
These values are also very close to the existing OEL for copper dust of 1 mg/m3 and as this value is currently used by many Member States as a legislative limit, it is proposed that this value is retained for the purposes of the REACH risk assessments and used as an inhalation local DNEL for copper. The corresponding OEL for copper fume is 0.1 mg/m3.
The external inhalation DNEL (short-term and long-term) is therefore:
1 mg/m3 for copper dust.
0.1 mg/m3 for copper fume.
External Dermal DNEL:
For screening purposes in the human health risk assessment, an external dermal DNEL (short-term and long-term) can be calculated using the proposed systemic DNELs (outlined above) and the proposed dermal penetration factors of 0.03% for dry copper and copper compounds and 0.3% for copper and copper compounds in solution/suspension.
The external long-term DNEL for dermal exposure has been set at 136.67 mg Cu/kg bw/d for dry copper and copper compounds.
The external short-term DNEL for dermal exposure has been set at 273.34 mg Cu/kg bw/d for dry copper and copper compounds.
The external long-term DNEL for dermal exposure has been set at 13.67 mg Cu/kg bw/d for copper and copper compounds in a slurry/solution.
The external short-term DNEL for dermal exposure has been set at 27.33 mg Cu/kg bw/d for copper and copper compounds in a slurry/solution.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.